In vivo performance evaluation and establishment of IVIVC for osmotic pump based extended release formulation of milnacipran HCl
- 11 April 2013
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 34 (4) , 227-235
Abstract
The objective of the present study was to carry out a pharmacokinetics evaluation of an oral modified release formulation [Aquarius EKX 19102 SRX–2 based osmotic pump (OP)] containing highly soluble milnacipran HCl (MH) as a model drug. It was also aimed at developing an in vitro–in vivo correlation (IVIVC) model for a developed OP. In vivo plasma concentration data were obtained from six healthy male New Zealand albino rabbits after administration of immediate‐release milnacipran HCl solution (IRMHSOL) and milnacipran HCl osmotic pump (MHOP). In vitro samples were analysed using an in house developed spectrophotometry method and in vivo samples were analysed using a RP‐HPLC method developed by the author. A deconvolution based Level A model was attempted through a correlation of the percent in vivo input obtained through deconvolution and the percent in vitro dissolution obtained experimentally. A good correlation between the percentages dissolved vs absorbed (R2 = 0.978) was obtained using level A correlation. Evaluation of the internal predictability of level A correlation was calculated in terms of the percent prediction error, which was found to be below 15%. In a nutshell, the success of the present study warrants further studies in patient volunteers to assess the ability of the MHOP to provide an effective therapy for depression. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- In vitro–in vivo correlation of modified release dosage form of lamotrigineBiopharmaceutics & Drug Disposition, 2009
- Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technologyActa Pharmaceutica, 2009
- Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drugEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Formulation Development and Human In Vitro‐In Vivo Correlation for a Novel, Monolithic Controlled‐Release Matrix System of High Load and Highly Water‐Soluble Drug NiacinDrug Development and Industrial Pharmacy, 2004
- Correlation of ‘in vitro’ release and ‘in vivo’ absorption characteristics of rifampicin from ethylcellulose coated nonpareil beadsInternational Journal of Pharmaceutics, 2001
- Osmotically Controlled Oral Drug Delivery*Drug Development and Industrial Pharmacy, 2000
- Pharmacokinetics of milnacipran in comparison with other antidepressantsInternational Clinical Psychopharmacology, 1996
- Controlled comparison of milnacipran and fluoxetine in major depressionPsychopharmacology, 1994
- In Vitro-ln Vivo Correlation for Modified-Release FormulationsJournal of Pharmaceutical Sciences, 1993
- Elementary Osmotic PumpJournal of Pharmaceutical Sciences, 1975